Target
Fatty acid-binding protein 5
Ligand
BDBM263071
Substrate
n/a
IC50
6660±n/a nM
Citation
 Buettelmann, BCeccarelli, SMConte, AKuehne, HKuhn, BNeidhart, WSander, UORichter, H Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors US Patent  US9708340 Publication Date 7/18/2017 
Target
Name:
Fatty acid-binding protein 5
Synonyms:
FABP5 | FABP5_HUMAN | Fatty acid binding protein epidermal | Fatty acid-binding protein 5 (FABP5)
Type:
Enzyme
Mol. Mass.:
15164.79
Organism:
Homo sapiens (Human)
Description:
Q01469
Residue:
135
Sequence:
MATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE
  
Inhibitor
Name:
BDBM263071
Synonyms:
US9708340, 64
Type:
Small organic molecule
Emp. Form.:
C18H16ClFN2O4
Mol. Mass.:
378.782
SMILES:
COc1cc(Cl)cc(NC(=O)N2CC[C@@H]2C(O)=O)c1-c1ccc(F)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: